Latest ebit for DCP.JO: $4.1B, below the sector sector average of $2.4T.
Get informed when a big investor buys or sells
+ FollowAs of Aug 31, 2026
Trailing 12 months ending Aug 31, 2026
As of the most recent data (August 2026), DCP.JO shows a EBIT of $4.1B. That compares with $3.6B in the prior-year period — up 14.2% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, DCP.JO's EBIT is now $4.1B (was $3.6B) — a 14.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Dis-Chem Pharmacies Limited is outperforming or lagging.
The its sector sector average EBIT is about $2.4T. Dis-Chem Pharmacies Limited is at $4.1B, which is lower that average. That is roughly 99.8% below the sector mean. Use the comparison chart on this page to see how DCP.JO stacks up against individual peers as well.
Tracking DCP.JO's ebit over time shows whether Dis-Chem Pharmacies Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $4.1B That compares with $3.6B in the prior-year period — up 14.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Dis-Chem Pharmacies Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $4.1B) with ownership activity and broader fundamentals.